Skip to main content

Natures Sunshine Products Inc

NATR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000275053

In the last 90 days, Natures Sunshine Products Inc insiders filed 2 open-market purchases and 0 sales; 153 institutions reported holding it in 13F filings for Q2 2026, worth $343.6M in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Natures Sunshine Products Inc changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of NATR: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders8279−3
Shares14.4M14.5M+133.2K (+0.9%)
Value$119.8M$138.2M+$18.4M (+15.3%)

New holders (10)

Institutions that held Natures Sunshine Products Inc at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to NATR in Q1 2023
InstitutionSharesValue% of portfolio
Pacific Ridge Capital Partners, LLC325,822$3.33M0.82%
CM Wealth Advisors LLC29,530$311.0K0.06%
O'Shaughnessy Asset Management, LLC14,387$146.9K0.00%
Millennium Management LLC11,042$113.0K0.00%
MetLife Investment Management7,135$72.8K0.00%
Metropolitan Life Insurance Co734$7.49K0.00%
Lindbrook Capital, LLC50$5110.00%
Northwestern Mutual Wealth Management Co47$4800.00%
Glassman Wealth Services18$1840.00%
Nisa Investment Advisors, LLC24$00.00%

Sold out (13)

Institutions that held Natures Sunshine Products Inc at the end of Q4 2022 and filed for Q1 2023 without it.